Distribution · GCC · Announced 12 Feb 2026
Misk Pharmaceutical Industries → UNIMED Laboratories
Jordan's Misk Pharmaceutical Industries appointed UNIMED as its exclusive UAE partner at WHX 2026, covering gastroenterology, respiratory, neurology and bone health products, with first shipments expected later in 2026.
Parties: Misk Pharmaceutical Industries (Jordan) → UNIMED (United Medical Supplies) (United Arab Emirates)
- Deal type
- Distribution
- Value
- Undisclosed
- Territory
- United Arab Emirates (exclusive)
- Therapeutic area
- Multi-therapy
- Asset
- Portfolio in gastroenterology, respiratory, neurology and bone health
- Announced
- 12 Feb 2026
Our analysis
Why this matters
Misk Pharmaceutical Industries of Jordan has appointed United Medical Supplies (UNIMED) LLC, part of the Mohamed & Obaid AlMulla Group, as its exclusive partner for entry into the United Arab Emirates. The agreement was signed at WHX 2026 in Dubai and announced on 12 February 2026. UNIMED will provide regulatory, logistics and supply-chain infrastructure and access to its hospital, clinic and pharmacy network, while Misk leads sales and marketing. The portfolio covers gastroenterology, respiratory, neurology and specialised bone health medicines, with first shipments expected later in 2026. No financial terms were disclosed.
For BD directors at Levant manufacturers, the split of roles is notable: the manufacturer keeps promotion while the distributor handles registration and logistics.
The full analysis is free to read with a work email on this page.
Source: Gulf News